作者
Soledad Ojeda,Rafael Manzanares,Pilar Jiménez‐Quevedo,Pablo Piñón,Lluís Asmarats,Ignacio J. Amat‐Santos,Eduard Fernández-Nofrerias,Raquel del Valle,Erika Muñoz‐García,María-Cruz Ferrer-Gracia,José María de la Torre,Valeriano Ruiz‐Quevedo,Ander Regueiro,Darío Sanmiguel,Sergio García‐Blas,Jaime Elı́zaga,José Antonio Baz,Rafael Romaguera,Ignacio Cruz‐González,José Moreu,Livia Gheorghe,Luisa Salido,Raúl Moreno,Cristóbal Urbano,Violeta Serra,Manuel Pan
摘要
Coronary obstruction (CO) following transcatheter aortic valve replacement (TAVR) is a life-threatening complication, scarcely studied.The authors analyzed the incidence of CO after TAVR, presentation, management, and in-hospital and 1-year clinical outcomes in a large series of patients undergoing TAVR.Patients from the Spanish TAVI (Transcatheter Aortic Valve Implantation) registry who presented with CO in the procedure, during hospitalization or at follow-up were included. Computed tomography (CT) risk factors were assessed. In-hospital, 30-day, and 1-year all-cause mortality rates were analyzed and compared with patients without CO using logistic regression models in the overall cohort and in a propensity score-matched cohort.Of 13,675 patients undergoing TAVR, 115 (0.80%) presented with a CO, mainly during the procedure (83.5%). The incidence of CO was stable throughout the study period (2009-2021), with a median annual rate of 0.8% (range 0.3%-1.3%). Preimplantation CT scans were available in 105 patients (91.3%). A combination of at least 2 CT-based risk factors was less frequent in native than in valve-in-valve patients (31.7% vs 78.3%; P < 0.01). Percutaneous coronary intervention was the treatment of choice in 100 patients (86.9%), with a technical success of 78.0%. In-hospital, 30-day, and 1-year mortality rates were higher in CO patients than in those without CO (37.4% vs 4.1%, 38.3% vs 4.3%, and 39.1% vs 9.1%, respectively; P < 0.001).In this large, nationwide TAVR registry, CO was a rare, but often fatal, complication that did not decrease over time. The lack of identifiable predisposing factors in a subset of patients and the frequently challenging treatment when established may partly explain these findings.